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LEARNING OBJECTIVES
To better understand the management of caesarean scar pregnancy (CSP) 
and to be able to recognize and to manage a potential complication of an in-
tervention used to treat CSP.
CSP is a rare location of ectopic pregnancy implanted in the area of the 
previous caesarean section (CS) scar. CSP is associated with a high risk of 
haemorrhage and in severe cases even a necessity to perform life saving 
hysterectomy. Selective uterine artery chemoembolization with intra-arterial 
methotrexate (MTX) infusion followed by suction curettage is one of the treat-
ment options available for CSP. Literature data on the possible complications 
of this treatment approach are scarce. 
CASE PRESENTATION
A 35-year-old female of Caucasian racial origin, one CS in her obstetrical 
history, was admitted to the hospital due to suspicion of CSP. Transvaginal 
ultrasound examination confirmed the initial diagnosis. The patient was quali-
fied for chemoembolization of uterine arteries and suction curettage of post 
cesarean scar implantation site. No complications were observed during these 
procedures. Four months after initial treatment the patient reported amenor-
rhea and pelvic pain. The suspicion of Asherman’s syndrome (AS) was consid-
ered and confirmed by transvaginal ultrasound (Fig. 1) and sonohysterography. 
The patient wished to preserve fertility and  because of this was qualified for 
hysteroscopy and simultaneous laparoscopy. Intrauterine adhesions were visu-
alized (Fig. 2) and deliberated (Fig. 3). Finally, chromopertubation confirmed 
the patency of both fallopian tubes. To prevent the recurrence of adhesions 
a copper containing intrauterine device (IUD) was inserted. Normal menses oc-
curred in this woman 35 days after the second stage of treatment. Intrauterine 
cavity location of the IUD was confirmed by transvaginal ultrasound (Fig. 4). 
The diagnosis of AS requires documentation of intrauterine adhesions in 
addition to clinical features such as amenorrhea, hypomenorrhea, subfertility 
or recurrent pregnancy loss. Transvaginal ultrasound is the first-line imaging 
method. The diagnosis may be confirmed by sonohysterography and, ulti-
mately, during hysteroscopy. The true prevalence of the reported complica-
tion is unknown, but ranges from 2% to 48% in prospective series of women 
following surgical evacuation of an early pregnancy loss. While dilatation and 
Figure 2. During hysteroscopy adhesions 
were seen within the entire uterine cavity, the 
diagnosis of AS was confirmed
Figure 1. Four months after chemoembolization 
and suction curettage of CSP transvaginal 
ultrasound examination performed in the 
luteal phase of the menstrual cycle revealed 
narrow endometrium with hypoechoic bands, 
suggestive of intrauterine adhesions in AS
Figure 3. Hysteroscopic image of the uterine 
cavity after adhesiolysis
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curettage with a sharp curette is a known risk factor for AS, there are no reports 
of AS following suction curettage. In our case the chemoembolization could 
have contributed to the formation of intrauterine adhesions. Currently, the 
recommended treatment of AS is hysteroscopic deliberation of adhesions. 
To the best of our knowledge there are no reported cases of AS after 
chemoembolization and suction curettage of CSP. Given the rarity of the 
presented case, the patients qualified for this procedure should be informed 
about the possible risk of the above complication. We believe that the physi-
cians should be aware of the possibility of AS following treatment of CSP, 
especially if amenorrhea develops after the intervention. Figure 4. Five weeks after hysteroscopic 
adhesiolysis the proper position of the IUD 
inserted to prevent recurrence of adhesions was 
confirmed by transvaginal ultrasound
